EPISODE · Feb 21, 2025 · 34 MIN
#97 - Three Breakthroughs: The AI Arms Race
from Tech Optimist: An Alumni Ventures Podcast · host Alumni Ventures
In this Three Breakthroughs episode of the Alumni Ventures Tech Optimist Podcast, host Mike Collins and Lucas Pasch explore three transformative advancements shaping the future. First, they break down the AI arms race, where tech giants like Google, Microsoft, and Amazon are pouring tens of billions into AI infrastructure, fueling competition and raising questions about market concentration and innovation. Next, they examine the unbundling of social media, with platforms like BlueSky gaining traction by offering decentralized, user-controlled experiences that challenge Big Tech’s dominance. Finally, they dive into a groundbreaking cancer vaccine trial from Dana-Farber, where personalized immunotherapy has delivered astonishing results—zero recurrences in advanced kidney cancer patients after three years. These breakthroughs are redefining industries and opening new possibilities for technology, medicine, and digital interaction. Tune in for a forward-looking discussion on where these shifts are headed next!To Learn More:Alumni Ventures (AV)AV LinkedInAV Deep Tech FundTech OptimistLegal Disclosure:https://av-funds.com/tech-optimist-disclosuresCreators & Guests Mike Collins - Host Lucas Pasch - Guest Shail Highbloom - Producer Sam Herrick - Producer Keith Murphy - Producer Jeannie Masters - Producer
What this episode covers
In this Three Breakthroughs episode of the Alumni Ventures Tech Optimist Podcast, host Mike Collins and Lucas Pasch explore three transformative advancements shaping the future. First, they break down the AI arms race, where tech giants like Google, Microsoft, and Amazon are pouring tens of billions into AI infrastructure, fueling competition and raising questions about market concentration and innovation. Next, they examine the unbundling of social media, with platforms like BlueSky gaining traction by offering decentralized, user-controlled experiences that challenge Big Tech’s dominance. Finally, they dive into a groundbreaking cancer vaccine trial from Dana-Farber, where personalized immunotherapy has delivered astonishing results—zero recurrences in advanced kidney cancer patients after three years. These breakthroughs are redefining industries and opening new possibilities for technology, medicine, and digital interaction. Tune in for a forward-looking discussion on where these shifts are headed next!To Learn More:Alumni Ventures (AV)AV LinkedInAV Deep Tech FundTech OptimistLegal Disclosure:https://av-funds.com/tech-optimist-disclosuresCreators & Guests Mike Collins - Host Lucas Pasch - Guest Shail Highbloom - Producer Sam Herrick - Producer Keith Murphy - Producer Jeannie Masters - Producer
NOW PLAYING
#97 - Three Breakthroughs: The AI Arms Race
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m